Epigallocatechin gallate can significantly decrease free oxygen radicals in the reperfusion injury in vivo. 2003

Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
Plastic Surgery, Department of General, Vascular and Thoracic Surgery, Medical Faculty (Charité), Humboldt-University of Berlin, Campus-Mitte, Schumannstrasse 20-21, 10117 Berlin, Germany. rolf.buettemeyer@charite.de

OBJECTIVE There is experimental evidence that oxygen-derived free radicals (Superoxide (O(2)(-))) play a key role in tissue damage in ischemia-reperfusion injury. Among various antioxidants tested in vitro, natural polyphenols like Epigallocatechine gallate (EGCG) show a 164-fold higher scavenging activity for O(2)(-) than ascorbic acid We therefore conducted an animal study in order to investigate the impact of EGCG on O(2)(-) production during reperfusion after defined periods of ischemia in the muscle tissue of the rat, using a recently developed cytochrome c-based biosensor for on-line in vivo monitoring of O(2)(-). METHODS Femoral artery and vein were dissected below the inguinal ligament in male Wistar rats. The cytochrome c-based biosensor was placed in the gastrocnemius muscle. Ischemia was induced by clamping the femoral vessels. Ischemia times were either 60 (n = 14) or 120 (n = 14) minutes. Six animals in each group received 4 mg/kg body weight EGCG intravenously at the time of reperfusion, another six animals in each group served as controls (no treatment). Additionally, two animals in each group received the same volume of saline instead of EGCG. The current response of the biosensor corresponding to the O(2)(-) concentrations in vivo was recorded on a PC. The gastrocnemius muscles were harvested for histological evaluation. RESULTS The average maximum O(2)(-) concentration after 60 minutes of ischemia was 188, 18 nmol/L (23 pA) compared to 90 nmol/L (11 pA) (P <.01) with EGCG application. The mean O(2)(-) value after 120 minutes was 220 nmol/L (27 pA) versus 135 nmol/L (16.5 pA) (P <.01) with EGCG, respectively. Histological analysis showed advanced muscle cell injury and neutrophil infiltration in the group without EGCG. No O(2)(-) reduction could be verified administering saline instead of EGCG. CONCLUSIONS For the first time the scavenging activity of an antioxidant was verified in vivo on-line. EGCG significantly diminished O(2)(-) tissue concentrations after 60 or 120 minutes of ischemia by an average of nearly 50%, suggesting its therapeutic potential.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common
D005268 Femoral Vein The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. Femoral Veins,Vein, Femoral,Veins, Femoral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
January 1995, Indian heart journal,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
January 1990, Methods in enzymology,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
July 1994, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
January 1988, Annals of emergency medicine,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
October 1994, Nihon Ika Daigaku zasshi,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
January 1989, Journal of reconstructive microsurgery,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
April 2011, Journal of receptor and signal transduction research,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
November 1989, The Journal of cardiovascular nursing,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
January 1986, Acta physiologica Scandinavica. Supplementum,
Rolf Büttemeyer, and A W Philipp, and L Schlenzka, and J W Mall, and M Beissenhirtz, and F Lisdat
January 1993, Zeitschrift fur Kardiologie,
Copied contents to your clipboard!